Delivery Order SPE2DB20D9226-SPE2DB25FQ59D
Award Date
3/20/25
Potential Completion Date
4/10/25
Potential Value
$8.3K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 68 mg Nexplanon contraceptive implants. The contract, valued at $14,293.80, has a completion date of June 4, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) worth up to $499,999,999, awarded to DMS Pharmaceutical Group by DLA under the SPE2DB program. The IDC allows DLA to issue delivery orders for...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,576.28 contract is for the delivery of 68 mg Nexplanon contraceptive implants, with an ultimate completion date of August 7, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business organization. The contract, valued at $102,915.36, is for the delivery of Nexplanon 68 mg implants, a contraceptive device. The contract has a performance period ending on March 18, 2024. DMS Pharmaceutical Group Inc. is an experienced pharmaceutical wholesaler that has held multiple prime vendor contracts with the Department of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $68,374.00 contract is for the supply of Nexplanon 68 MG contraceptive implants, with a period of performance through February 21, 2023. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999 and running through December 31, 2025....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $2,459.84 and is for the delivery of 4,558,999 units of the contraceptive implant Nexplanon 68 mg. The order has a completion date of November 25, 2022. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $3,573.45, is for the delivery of Nexplanon 68 mg implants. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, which allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,146.90, is for the delivery of Nexplanon 68 mg implants, a contraceptive product. The contract has an ultimate completion date of October 8, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,452.96, is for the supply of Nexplanon 68 mg contraceptive implants. This delivery order is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which allows the agency to issue firm...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,573.45 award is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive medical device, with a completion date of June 6, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,864.42, is for the delivery of Nexplanon 68 mg implants, a type of contraceptive implant. The contract has an ultimate completion date of August 23, 2024 and is not set aside for any specific business category. DMS Pharmaceutical Group Inc. is a key...